Lv3
236 积分 2021-08-18 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
3小时前
已完结
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
8天前
已完结
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
12天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
18天前
已完结
Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple Myeloma
27天前
已完结
PD1 agonist antibody passes first phase II trial for autoimmune disease
28天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
CAR T-cell therapy in advanced gastro-oesophageal cancer
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
皖公网安备34019202002308
